The pretreatment albumin-globulin ratio can independently predict survival outcomes in patients with urothelial carcinoma, according to a recent meta-analysis. Zhongyou Xia of the Nanchong Central Hospital, The Second Clinical College, North Sichuan Medical College, and colleagues conducted the analysis and published its results in Frontiers in Oncology. ...
Advertisement
Latest News
Researchers identified the top reason why some patients with urothelial carcinoma don't pursue treatment.
Shilpa Gupta, MD, discusses recent developments in targeted molecular therapeutics for advanced bladder cancer.
Enfortumab vedotin plus pembrolizumab led to an ORR of 73.3% in cisplatin-ineligible patients with urothelial cancer.
Neoadjuvant platinum-based chemotherapy has been found effective for treating metastatic penile squamous cell carcinoma.
A new study has found an association between neurodevelopmental disorders and testicular seminoma.
CLEAR study results showed that treatment with first-line lenvatinib plus pembrolizumab had clinical benefit at 2 years.
Advertisement
Advertisement
Editorial Advisory Board
Catherine H. Marshall, MD, MPHEditor-in-Chief | Assistant Professor of Oncology at the Johns Hopkins University School of Medicine
Jérémie Calais, MD, MScEditor | Director of the Theranostics and Clinical Research Programs at the University of California, Los Angeles
Akhil Abraham Saji, MDAssociate Editor | Urology Resident at New York Medical College/Westchester Medical Center
David Ambinder, MDAssociate Editor | Urology Resident at New York Medical College/Westchester Medical Center
Knowledge Hubs
Curated clinical content based on conditions, therapies, and technologies
GU Oncology Now delivers the latest news in clinical trials, conference coverage, and more, highlighting advancements in genitourinary oncology treatments and tech.
Get research and breaking news straight to your inbox.
Conference Coverage
Live meeting highlights
A new study has found an association between neurodevelopmental disorders and testicular seminoma.
CLEAR study results showed that treatment with first-line lenvatinib plus pembrolizumab had clinical benefit at 2 years.
The RACE IT trial finds neoadjuvant radio-immunotherapy followed by radical cystectomy a safe and feasible treatment option.
Patients with mCRPC with AR alterations had significantly worse survival outcomes compared with patients with wild-type.
The Uromigos
Podcasts hosted by Professors Thomas Powles, MD, and Brian Rini, MD
Roundtables
Clinical discussions with experts in the field
Journal
Articles from the GU Oncology Now Journal
Rectal spacing technology can reduce radiation exposure to nontarget organs, which decreases toxicity.
A review of a series of articles published by Urology on diversity, equity, and inclusion findings in prostate cancer care.
Studies on the use of cytoreductive nephrectomy in mRCC are reviewed, including its role among TKIs and immunotherapy.
A report examines the correlation between family history of prostate cancer and risk of progression after prostatectomy.
Dr. Stacy Loeb is interviewed on the use of active surveillance for prostate cancer, its history, and new insights.
Catherine Handy Marshall reviews her career from cardiovascular disease research to prostate cancer risk factors & genetics.
Network Websites
Blood Cancers Today provides hematologists and oncologists with news, education, and information relevant to their patients and practices. Featuring the most current information from around the specialty, it offers insights and exclusive interviews from experts in the field.
Cancer Nursing Today delivers critical news and information to support oncology nurses throughout their education and careers, with the goal of advancing oncology treatments and care and promoting the nurse’s role in enhanced patient outcomes and quality of life.
Urban Health Today is the leading independent news source that provides urban healthcare professionals with relevant clinical news and policy developments that impact patients. Its coverage focuses on clinical, social, and environmental health disparities.
MashupMD is a leading medical news aggregator, optimized for rapid access to the latest headlines in the medical world, providing a collection, or “mashup,” of key medical content based on what your colleagues are reading and sharing on social media.
